Notice: This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DEH vs. CDRE, ESTA, AVNS, SMTI, INGN, ZJYL, LAKE, SPAI, RBOT, and APTShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Jin Medical International (ZJYL), Lakeland Industries (LAKE), Safe Pro Group Inc. Common Stock (SPAI), Vicarious Surgical (RBOT), and Alpha Pro Tech (APT). D8 vs. Cadre Establishment Labs Avanos Medical Sanara MedTech Inogen Jin Medical International Lakeland Industries Safe Pro Group Inc. Common Stock Vicarious Surgical Alpha Pro Tech D8 (NYSE:DEH) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations. Does the MarketBeat Community believe in DEH or CDRE? Cadre received 16 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformD8N/AN/ACadreOutperform Votes1655.17% Underperform Votes1344.83% Is DEH or CDRE more profitable? Cadre has a net margin of 6.34% compared to D8's net margin of 0.00%. Cadre's return on equity of 12.88% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets D8N/A N/A N/A Cadre 6.34%12.88%6.06% Does the media prefer DEH or CDRE? In the previous week, Cadre had 5 more articles in the media than D8. MarketBeat recorded 5 mentions for Cadre and 0 mentions for D8. Cadre's average media sentiment score of -0.05 beat D8's score of -0.73 indicating that Cadre is being referred to more favorably in the news media. Company Overall Sentiment D8 Negative Cadre Neutral Do insiders & institutionals believe in DEH or CDRE? 65.4% of D8 shares are held by institutional investors. Comparatively, 44.0% of Cadre shares are held by institutional investors. 37.0% of Cadre shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better earnings and valuation, DEH or CDRE? Cadre has higher revenue and earnings than D8. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioD8N/AN/A-$9.46MN/AN/ACadre$482.53M2.76$38.64M$0.8339.51 Do analysts prefer DEH or CDRE? Cadre has a consensus price target of $39.75, indicating a potential upside of 21.23%. Given Cadre's stronger consensus rating and higher probable upside, analysts clearly believe Cadre is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cadre 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SummaryCadre beats D8 on 12 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$443.76M$9.82B$5.14B$20.11BDividend YieldN/A1.10%5.05%3.49%P/E RatioN/A23.43132.3743.37Price / SalesN/A28.531,231.9918.40Price / CashN/A23.2340.0621.28Price / Book85.754.856.954.65Net Income-$9.46M$182.72M$119.48M$985.54M D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$10.29+14.0%N/A+2,893.5%$443.76MN/A0.003CDRECadre3.4227 of 5 stars$32.79+1.1%$39.75+21.2%+1.4%$1.33B$482.53M39.512,435Insider TradeESTAEstablishment Labs1.9839 of 5 stars$42.61+1.9%$60.60+42.2%+90.0%$1.19B$165.15M-16.63960AVNSAvanos Medical4.0029 of 5 stars$18.02+0.8%N/A-16.6%$828.20M$673.30M54.003,771Positive NewsSMTISanara MedTech1.1845 of 5 stars$37.10-0.5%$44.00+18.6%+17.2%$324.29M$64.99M-37.4860INGNInogen3.0927 of 5 stars$9.21-2.6%$7.00-24.0%+63.4%$225.32M$331.52M-4.09834ZJYLJin Medical InternationalN/A$1.07+5.9%N/A-94.1%$165.85M$19.82M0.00245Positive NewsLAKELakeland Industries3.9483 of 5 stars$21.99+4.0%$26.50+20.5%+44.7%$162.73M$124.69M91.631,750News CoverageSPAISafe Pro Group Inc. Common StockN/A$4.47+39.7%N/AN/A$61.51MN/A0.0011News CoverageGap UpTrading HaltedHigh Trading VolumeRBOTVicarious Surgical0.9878 of 5 stars$10.29+14.0%$10.25-0.4%-26.1%$60.71MN/A-1.003News CoverageAPTAlpha Pro TechN/A$5.38+2.7%N/A+11.1%$59.18M$61.23M14.54120 Related Companies and Tools Related Companies CDRE Competitors ESTA Competitors AVNS Competitors SMTI Competitors INGN Competitors ZJYL Competitors LAKE Competitors SPAI Competitors RBOT Competitors APT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:DEH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
